Therapeutic Challenges of Non- Aspergillus Invasive Mold Infections in Immunosuppressed Patients
- PMID: 31481441
- PMCID: PMC6811444
- DOI: 10.1128/AAC.01244-19
Therapeutic Challenges of Non- Aspergillus Invasive Mold Infections in Immunosuppressed Patients
Abstract
While Aspergillus spp. remain the major cause of invasive mold infections in hematologic cancer patients and transplant recipients, other opportunistic molds, such as Mucorales, Fusarium, and Scedosporium spp. are increasingly encountered in an expanding population of patients with severe and prolonged immunosuppression. High potential for tissue invasion and dissemination, resistance to multiple antifungals and high mortality rates are hallmarks of these non-Aspergillus invasive mold infections (NAIMIs). Assessment of drug efficacy is particularly difficult in the complex treatment scenarios of NAIMIs. Specifically, correlation between in vitro susceptibility and in vivo responses to antifungals is hard to assess, in view of the multiple, frequently interrelated factors influencing outcomes, such as pharmacokinetic/pharmacodynamic parameters determining drug availability at the site of infection, the net state of immune suppression, delay in diagnosis, or surgical debulking of infectious foci. Our current therapeutic approach of NAIMIs should evolve toward a better integration of the dynamic interactions between the pathogen, the drug and the host. Innovative concepts of experimental research may consist in manipulating the host immune system to induce a specific antifungal response or targeted drug delivery. In this review, we discuss the challenges in the management of NAIMIs and provide an update about the latest advances in diagnostic and therapeutic approaches.
Keywords: Fusarium; Lomentospora; Mucor; Rhizopus; Scedosporium; amphotericin B; azole; fusariosis; isavuconazole; mucormycosis; posaconazole; scedosporiosis; voriconazole.
Copyright © 2019 American Society for Microbiology.
Figures


Similar articles
-
Changes in the epidemiological landscape of invasive mould infections and disease.J Antimicrob Chemother. 2017 Mar 1;72(suppl_1):i5-i11. doi: 10.1093/jac/dkx028. J Antimicrob Chemother. 2017. PMID: 28355462
-
Rare mould infections caused by Mucorales, Lomentospora prolificans and Fusarium, in San Diego, CA: the role of antifungal combination therapy.Int J Antimicrob Agents. 2018 Nov;52(5):706-712. doi: 10.1016/j.ijantimicag.2018.08.005. Epub 2018 Aug 9. Int J Antimicrob Agents. 2018. PMID: 30099056 Free PMC article.
-
Non-Aspergillus Hyaline Molds: Emerging Causes of Sino-Pulmonary Fungal Infections and Other Invasive Mycoses.Semin Respir Crit Care Med. 2020 Feb;41(1):115-130. doi: 10.1055/s-0039-3401989. Epub 2020 Jan 30. Semin Respir Crit Care Med. 2020. PMID: 32000288 Review.
-
The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis).J Antimicrob Chemother. 2016 Nov;71(suppl 2):ii31-ii36. doi: 10.1093/jac/dkw394. J Antimicrob Chemother. 2016. PMID: 27880667
-
Invasive mould infections in the ICU setting: complexities and solutions.J Antimicrob Chemother. 2017 Mar 1;72(suppl_1):i39-i47. doi: 10.1093/jac/dkx032. J Antimicrob Chemother. 2017. PMID: 28355466 Review.
Cited by
-
Nebulized Micafungin Treatment for Scopulariopsis/Microascus Tracheobronchitis in Lung Transplant Recipients.Antimicrob Agents Chemother. 2021 May 18;65(6):e02174-20. doi: 10.1128/AAC.02174-20. Print 2021 May 18. Antimicrob Agents Chemother. 2021. PMID: 33722884 Free PMC article.
-
Antifungal Activity of Isavuconazole and Comparator Agents against Contemporaneous Mucorales Isolates from USA, Europe, and Asia-Pacific.J Fungi (Basel). 2023 Feb 11;9(2):241. doi: 10.3390/jof9020241. J Fungi (Basel). 2023. PMID: 36836355 Free PMC article.
-
Isavuconazole for the Treatment of Fungal Infections: A Real-life Experience From the Fungal Infection Network of Switzerland (FUNGINOS).Open Forum Infect Dis. 2024 Apr 26;11(5):ofae223. doi: 10.1093/ofid/ofae223. eCollection 2024 May. Open Forum Infect Dis. 2024. PMID: 38756765 Free PMC article.
-
American Society of Transplantation and Cellular Therapy Series, 2: Management and Prevention of Aspergillosis in Hematopoietic Cell Transplantation Recipients.Transplant Cell Ther. 2021 Mar;27(3):201-211. doi: 10.1016/j.jtct.2020.10.003. Transplant Cell Ther. 2021. PMID: 33781516 Free PMC article.
-
Non-Aspergillus Hyaline Molds: A Host-Based Perspective of Emerging Pathogenic Fungi Causing Sinopulmonary Diseases.J Fungi (Basel). 2023 Feb 6;9(2):212. doi: 10.3390/jof9020212. J Fungi (Basel). 2023. PMID: 36836326 Free PMC article. Review.
References
-
- Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, Ito J, Andes DR, Baddley JW, Brown JM, Brumble LM, Freifeld AG, Hadley S, Herwaldt LA, Kauffman CA, Knapp K, Lyon GM, Morrison VA, Papanicolaou G, Patterson TF, Perl TM, Schuster MG, Walker R, Wannemuehler KA, Wingard JR, Chiller TM, Pappas PG. 2010. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 50:1091–1100. doi:10.1086/651263. - DOI - PubMed
-
- Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J, Pfaller M, Chang C, Webster K, Marr K. 2009. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 48:265–273. doi:10.1086/595846. - DOI - PubMed
-
- Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, Anaissie EJ, Brumble LM, Herwaldt L, Ito J, Kontoyiannis DP, Lyon GM, Marr KA, Morrison VA, Park BJ, Patterson TF, Perl TM, Oster RA, Schuster MG, Walker R, Walsh TJ, Wannemuehler KA, Chiller TM. 2010. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 50:1101–1111. doi:10.1086/651262. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous